These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 29282221)
1. Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma. Xiao W; Zhang R; Sohrabi A; Ehsanipour A; Sun S; Liang J; Walthers CM; Ta L; Nathanson DA; Seidlits SK Cancer Res; 2018 Mar; 78(5):1358-1370. PubMed ID: 29282221 [TBL] [Abstract][Full Text] [Related]
4. A preclinical orthotopic model for glioblastoma recapitulates key features of human tumors and demonstrates sensitivity to a combination of MEK and PI3K pathway inhibitors. El Meskini R; Iacovelli AJ; Kulaga A; Gumprecht M; Martin PL; Baran M; Householder DB; Van Dyke T; Weaver Ohler Z Dis Model Mech; 2015 Jan; 8(1):45-56. PubMed ID: 25431423 [TBL] [Abstract][Full Text] [Related]
5. The Potential of the Fibronectin Inhibitor Arg-Gly-Asp-Ser in the Development of Therapies for Glioblastoma. Castro-Ribeiro ML; Castro VIB; Vieira de Castro J; Pires RA; Reis RL; Costa BM; Ferreira H; Neves NM Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732135 [TBL] [Abstract][Full Text] [Related]
6. A biomaterial screening approach reveals microenvironmental mechanisms of drug resistance. Schwartz AD; Barney LE; Jansen LE; Nguyen TV; Hall CL; Meyer AS; Peyton SR Integr Biol (Camb); 2017 Dec; 9(12):912-924. PubMed ID: 29159332 [TBL] [Abstract][Full Text] [Related]
7. Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors. Pavlyukov MS; Yu H; Bastola S; Minata M; Shender VO; Lee Y; Zhang S; Wang J; Komarova S; Wang J; Yamaguchi S; Alsheikh HA; Shi J; Chen D; Mohyeldin A; Kim SH; Shin YJ; Anufrieva K; Evtushenko EG; Antipova NV; Arapidi GP; Govorun V; Pestov NB; Shakhparonov MI; Lee LJ; Nam DH; Nakano I Cancer Cell; 2018 Jul; 34(1):119-135.e10. PubMed ID: 29937354 [TBL] [Abstract][Full Text] [Related]
8. Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood-Brain Barrier. Tang M; Rich JN; Chen S Adv Mater; 2021 Feb; 33(5):e2004776. PubMed ID: 33326131 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia activates enhanced invasive potential and endogenous hyaluronic acid production by glioblastoma cells. Chen JE; Lumibao J; Blazek A; Gaskins HR; Harley B Biomater Sci; 2018 Mar; 6(4):854-862. PubMed ID: 29485655 [TBL] [Abstract][Full Text] [Related]
10. RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma. Jermakowicz AM; Kurimchak AM; Johnson KJ; Bourgain-Guglielmetti F; Kaeppeli S; Affer M; Pradhyumnan H; Suter RK; Walters W; Cepero M; Duncan JS; Ayad NG Sci Rep; 2024 Apr; 14(1):9284. PubMed ID: 38654040 [TBL] [Abstract][Full Text] [Related]
11. The Influence of Hyaluronic Acid and Glioblastoma Cell Coculture on the Formation of Endothelial Cell Networks in Gelatin Hydrogels. Ngo MT; Harley BA Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941173 [TBL] [Abstract][Full Text] [Related]
12. The Combined Influence of Hydrogel Stiffness and Matrix-Bound Hyaluronic Acid Content on Glioblastoma Invasion. Chen JE; Pedron S; Harley BAC Macromol Biosci; 2017 Aug; 17(8):. PubMed ID: 28379642 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effect of Cabazitaxel and Blood-Brain Barrier opening in a Patient-Derived Glioblastoma Model. Sulheim E; Mørch Y; Snipstad S; Borgos SE; Miletic H; Bjerkvig R; Davies CL; Åslund AKO Nanotheranostics; 2019; 3(1):103-112. PubMed ID: 30899638 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic Mechanisms Histone Deacetylase-Dependent Regulate the Glioblastoma Angiogenic Matrisome and Disrupt Endothelial Cell Behavior In Vitro. Menezes A; Julião G; Mariath F; Ferreira AL; Oliveira-Nunes MC; Gallucci L; Evaristo JAM; Nogueira FCS; Pereira DA; Carneiro K Mol Cell Proteomics; 2024 Mar; 23(3):100722. PubMed ID: 38272115 [TBL] [Abstract][Full Text] [Related]
16. A composite hydrogel platform for the dissection of tumor cell migration at tissue interfaces. Rape AD; Kumar S Biomaterials; 2014 Oct; 35(31):8846-8853. PubMed ID: 25047626 [TBL] [Abstract][Full Text] [Related]
18. Improving the efficacy of anti-EGFR drugs in GBM: Where we are going? Ge M; Zhu Y; Wei M; Piao H; He M Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188996. PubMed ID: 37805108 [TBL] [Abstract][Full Text] [Related]
19. Matrix Stiffness Modulates Patient-Derived Glioblastoma Cell Fates in Three-Dimensional Hydrogels. Wang C; Sinha S; Jiang X; Murphy L; Fitch S; Wilson C; Grant G; Yang F Tissue Eng Part A; 2021 Mar; 27(5-6):390-401. PubMed ID: 32731804 [TBL] [Abstract][Full Text] [Related]
20. The role of pore size and mechanical properties on the accumulation, retention and distribution of F98 glioblastoma cells in macroporous hydrogels. Delattre L; Naasri S; Solano AG; Therriault H; Bergeron-Fortier S; Moreau V; Liberelle B; Crescenzo G; Lauzon MA; Faucheux N; Paquette B; Virgilio N Biomed Mater; 2024 Jun; 19(4):. PubMed ID: 38870993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]